We are live on ! Find out more
Baird Financial Group

Baird Financial Group Portfolio holdings

AUM $64B
1-Year Est. Return 22.64%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+22.64%
3 Year Est. Return
+71.5%
5 Year Est. Return
+89.73%
10 Year Est. Return
+347.75%
AUM
$51.5B
AUM Growth
+$3.29B
Cap. Flow
+$48.7M
Cap. Flow %
0.09%
Top 10 Hldgs %
24.01%
Holding
1,850
New
97
Increased
775
Reduced
779
Closed
103

Top Sells

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$75.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$53.9M
3
APTV icon
Aptiv
APTV
+$52.3M
4
BSY icon
Bentley Systems
BSY
+$49.8M
5
LSCC icon
Lattice Semiconductor
LSCC
+$48.2M

Sector Composition

Rank Sector Weight
1 Technology 19.02%
2 Financials 13.13%
3 Industrials 10.63%
4 Consumer Discretionary 8.31%
5 Healthcare 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
1726
Molina Healthcare
MOH
$10.4B
$50.6K ﹤0.01%
147
-2,524
-94% -$833K
OPAL icon
1727
OPAL Fuels
OPAL
$62.5M
$48.4K ﹤0.01%
13,249
MD icon
1728
Pediatrix Medical
MD
$2.2B
$46.4K ﹤0.01%
4,000
-13,677
-77% -$129K
SANA icon
1729
Sana Biotechnology
SANA
$882M
$41.6K ﹤0.01%
+10,000
New +$52.5K
LNTH icon
1730
Lantheus
LNTH
$6.51B
$36.8K ﹤0.01%
335
-10,597
-97% -$1.1M
NGD
1731
DELISTED
New Gold Inc
NGD
$36.5K ﹤0.01%
12,675
+1,175
+10% +$2.9K
WD icon
1732
Walker & Dunlop
WD
$1.73B
$35.9K ﹤0.01%
+316
New +$33.1K
BTG icon
1733
B2Gold
BTG
$4.98B
$32.3K ﹤0.01%
10,500
-2,000
-16% -$5.81K
CLLS
1734
Cellectis
CLLS
$288M
$32K ﹤0.01%
15,090
KPTI icon
1735
Karyopharm Therapeutics
KPTI
$155M
$31.4K ﹤0.01%
2,520
+67
+3% +$833
GSAT icon
1736
Globalstar
GSAT
$10.1B
$31K ﹤0.01%
1,667
EHAB
1737
DELISTED
Enhabit
EHAB
$30.7K ﹤0.01%
3,886
-7,248
-65% -$63K
ENTG icon
1738
Entegris
ENTG
$16.3B
$27K ﹤0.01%
+240
New +$28.4K
CHPT icon
1739
ChargePoint
CHPT
$134M
$23.6K ﹤0.01%
861
-540
-39% -$18.8K
WBX
1740
Wallbox
WBX
$76.7M
$23.1K ﹤0.01%
947
-39
-4% -$1.06K
AKBA icon
1741
Akebia Therapeutics
AKBA
$338M
$23K ﹤0.01%
17,393
CERS icon
1742
Cerus
CERS
$575M
$20.8K ﹤0.01%
11,950
EHC icon
1743
Encompass Health
EHC
$11.3B
$19.3K ﹤0.01%
+200
New +$18K
BLUE
1744
DELISTED
bluebird bio
BLUE
$16.8K ﹤0.01%
1,613
-1,500
-48% -$24.9K
NAK
1745
Northern Dynasty Minerals
NAK
$773M
$10.1K ﹤0.01%
30,600
CMRX
1746
DELISTED
Chimerix, Inc.
CMRX
$9.3K ﹤0.01%
10,000
AVK.RT
1747
DELISTED
Advent Convertible and Income Fund Rights
AVK.RT
$4.09K ﹤0.01%
+205,705
New +$11.6K
AA icon
1748
Alcoa
AA
$11.3B
-90,219
Closed -$3.59M
AMN icon
1749
AMN Healthcare
AMN
$1.35B
-14,173
Closed -$726K
AR icon
1750
Antero Resources
AR
$10.9B
-10,014
Closed -$327K

Similar funds

Baird Financial Group's Q3 2024 Portfolio in Review

As of Q3 2024, Baird Financial Group held 1,850 positions worth $51.5B, up 6.8% from $48.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Baird Financial Group's Q3 2024 filing shows 97 new, 775 increased, 779 reduced and 103 closed positions. Its largest new stake was Ryanair: 465,778 shares worth $21M. The largest sale was Watsco Inc, an estimated $75.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

  • Baird Financial Group's largest Q3 2024 buy was Ryanair: 465,778 shares worth $21M.
  • Baird Financial Group added most to iShares Russell 1000 Value ETF in Q3 2024, an estimated $126M increase.
  • Baird Financial Group's biggest Q3 2024 reduction was Watsco Inc, cutting an estimated $75.4M.
  • Baird Financial Group fully exited Bentley Systems in Q3 2024, selling an estimated $49.8M.
  • Baird Financial Group's ten largest holdings make up 24% of its $51.5B portfolio in Q3 2024.
  • Baird Financial Group opened 97 new positions and closed 103 in Q3 2024.
  • Baird Financial Group's portfolio value rose 6.8% quarter-over-quarter to $51.5B.

Based on Baird Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.